540729 — Vanta Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹403.97m
- IN₹996.97m
- IN₹62.76m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | ARS |
Standards: | IAS | IAS | IAS | — | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 11 | 13.4 | 5.89 | 2.28 | -103 |
Depreciation | |||||
Non-Cash Items | 16.9 | 19.5 | 21.2 | 23.5 | 58.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -47.7 | -23.7 | 29.1 | 13.3 | 10.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.7 | 21.1 | 68.7 | 52.2 | -6.28 |
Capital Expenditures | -24.8 | -73.5 | -222 | -172 | -287 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -30.2 | 0 | 0 | — | 228 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -55 | -73.5 | -222 | -172 | -59.1 |
Financing Cash Flow Items | -16.9 | -19.5 | -21.4 | -23.5 | -58.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 99.4 | 21.7 | 178 | 95.3 | 64.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 31.8 | -30.7 | 24.6 | -24.3 | -1.28 |